HomeComparePOFCY vs MRK

POFCY vs MRK: Dividend Comparison 2026

POFCY yields 666666.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POFCY wins by $3843184858461165056.00M in total portfolio value
10 years
POFCY
POFCY
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3843184858461165056.00M
Annual income
$2,951,404,776,098,759,000,000,000.00
Full POFCY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — POFCY vs MRK

📍 POFCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPOFCYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POFCY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POFCY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POFCY
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$2,508,694,059,683,945,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, POFCY beats the other by $2,508,694,059,683,945,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POFCY + MRK for your $10,000?

POFCY: 50%MRK: 50%
100% MRK50/50100% POFCY
Portfolio after 10yr
$1921592429230582528.00M
Annual income
$1,475,702,388,049,379,400,000,000.00/yr
Blended yield
76.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

POFCY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POFCY buys
0
MRK buys
0
No recent congressional trades found for POFCY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPOFCYMRK
Forward yield666666.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$3843184858461165056.00M$56.8K
Annual income after 10y$2,951,404,776,098,759,000,000,000.00$9,798.13
Total dividends collected$3777696863071325696.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: POFCY vs MRK ($10,000, DRIP)

YearPOFCY PortfolioPOFCY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$33,344,033$33,333,333.33$11,206$366.19+$33.33MPOFCY
2$51,973,424,741$51,937,746,625.13$12,650$502.35+$51973.41MPOFCY
3$37,885,279,905,810$37,829,668,341,337.28$14,407$694.19+$37885279.89MPOFCY
4$12,926,234,563,052,674$12,885,697,313,553,460.00$16,585$967.82+$12926234563.04MPOFCY
5$2,068,281,583,056,657,700$2,054,450,512,074,191,400.00$19,342$1,363.89+$2068281583056.64MPOFCY
6$155,823,080,460,537,230,000$153,610,019,166,666,620,000.00$22,913$1,947.19+$155823080460537.19MPOFCY
7$5,574,621,214,635,156,000,000$5,407,890,518,542,381,000,000.00$27,662$2,823.89+$5574621214635156.00MPOFCY
8$96,370,936,431,909,830,000,000$90,406,091,732,250,210,000,000.00$34,159$4,173.35+$96370936431909824.00MPOFCY
9$833,439,329,310,660,000,000,000$730,322,427,328,516,400,000,000.00$43,337$6,308.80+$833439329310659968.00MPOFCY
10$3,843,184,858,461,165,000,000,000$2,951,404,776,098,759,000,000,000.00$56,776$9,798.13+$3843184858461165056.00MPOFCY

POFCY vs MRK: Complete Analysis 2026

POFCYStock

Petrofac Limited designs, builds, manages, and maintains infrastructure for the energy industries in the United Kingdom, Algeria, Thailand, Oman, Kuwait, Iraq, the United Arab Emirates, the Netherlands, and internationally. It operates through three segments: Engineering & Construction (E&C); Asset Solutions; and Integrated Energy Services (IES). The E&C segment provides onshore and offshore engineering, procurement, construction, installation, and commissioning services. The Asset Solutions segment offers concept, feasibility, and front-end engineering design services, as well as manages and maintains onshore and offshore operations. The IES segment provides an integrated services for clients under flexible commercial models that are aligned with their requirements. Petrofac Limited was founded in 1981 and is based in St Helier, Jersey.

Full POFCY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this POFCY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POFCY vs SCHDPOFCY vs JEPIPOFCY vs OPOFCY vs KOPOFCY vs MAINPOFCY vs JNJPOFCY vs ABBVPOFCY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.